当前蛋白身份:Q15418 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
2WNT Crystal Structure of the Human Ribosomal protein S6 kinase 提交 2009-07-20 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–719(307 aa) 片段:RESIDUES 413-719
链 B 413–719(307 aa) 片段:RESIDUES 413-719
未记录 NA SODIUM ION × 3 CL CHLORIDE ION × 1 PEG DI(HYDROXYETHYL)ETHER × 2 X-RAY DIFFRACTION
X-ray结晶条件 20% PEG 3350, 0.20M NA(FORM)
分辨率 2.40 Å R-free 0.240
2Z7Q Crystal structure of the N-terminal kinase domain of human RSK-1 bound to AMP-PCP 提交 2007-08-28 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 33–353(321 aa) 片段:Residues 33-353
未记录 MG MAGNESIUM ION × 1 ACP PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;12-16% PEG MME 2000, 150mM DL-malic acid, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.00 Å R-free 0.283
2Z7R Crystal Structure of the N-terminal Kinase Domain of Human RSK1 bound to Staurosporine 提交 2007-08-28 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 33–353(321 aa) 片段:Residues 33-353
未记录 STU STAUROSPORINE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;12-16% PEG MME 2000, 150mM DL-malic acid, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.00 Å R-free 0.286
2Z7S Crystal Structure of the N-terminal Kinase Domain of Human RSK1 bound to Purvalnol A 提交 2007-08-28 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 33–353(321 aa) 片段:Residues 33-353
未记录 P01 2-({6-[(3-CHLOROPHENYL)AMINO]-9-ISOPROPYL-9H-PURIN-2-YL}AMINO)-3-METHYLBUTAN-1-OL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;12-16% PEG MME 2000, 150mM DL-malic acid , pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.10 Å
3RNY Crystal structure of human RSK1 C-terminal kinase domain 提交 2011-04-24 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 411–735(325 aa) 片段:UNP residues 411-735
未记录 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;290 K;0.1 M HEPES pH 7.5, 17.1%(w/v) PEG 3350, 4%(v/v) acetonitrile or 18%(w/v) PEG 3350, 100 mM ammonium formate, 4%(v/v) acetonitrile, vapor diffusion, sitting drop, temperature 290K
分辨率 2.70 Å R-free 0.238
3RNY Crystal structure of human RSK1 C-terminal kinase domain 提交 2011-04-24 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 411–735(325 aa) 片段:UNP residues 411-735
未记录 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;290 K;0.1 M HEPES pH 7.5, 17.1%(w/v) PEG 3350, 4%(v/v) acetonitrile or 18%(w/v) PEG 3350, 100 mM ammonium formate, 4%(v/v) acetonitrile, vapor diffusion, sitting drop, temperature 290K
分辨率 2.70 Å R-free 0.238
3RNY Crystal structure of human RSK1 C-terminal kinase domain 提交 2011-04-24 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 411–735(325 aa) 片段:UNP residues 411-735
链 B 411–735(325 aa) 片段:UNP residues 411-735
未记录 NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;290 K;0.1 M HEPES pH 7.5, 17.1%(w/v) PEG 3350, 4%(v/v) acetonitrile or 18%(w/v) PEG 3350, 100 mM ammonium formate, 4%(v/v) acetonitrile, vapor diffusion, sitting drop, temperature 290K
分辨率 2.70 Å R-free 0.238
3TEI Crystal structure of human ERK2 complexed with a MAPK docking peptide 提交 2011-08-15 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 712–735(24 aa) 片段:C-TERMINAL DOCKING PEPTIDE, RESIDUES 712-735
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;296 K;27-29% PEG 6000, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K
分辨率 2.40 Å R-free 0.235
4H3P Crystal structure of human ERK2 complexed with a MAPK docking peptide 提交 2012-09-14 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 712–735(24 aa) 片段:C-TERMINAL DOCKING PEPTIDE, UNP residues 712-735
突变:S719A, Q724A ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;296 K;25-30% PEG6000, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K
分辨率 2.30 Å R-free 0.224
4H3P Crystal structure of human ERK2 complexed with a MAPK docking peptide 提交 2012-09-14 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 E 712–735(24 aa) 片段:C-TERMINAL DOCKING PEPTIDE, UNP residues 712-735
突变:S719A, Q724A ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;296 K;25-30% PEG6000, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K
分辨率 2.30 Å R-free 0.224
4NIF Heterodimeric structure of ERK2 and RSK1 提交 2013-11-06 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 411–735(325 aa) 片段:C-terminal kinase domain, UNP residues 411-735
链 D 411–735(325 aa) 片段:C-terminal kinase domain, UNP residues 411-735
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2 SO4 SULFATE ION × 3 NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.25;296 K;0.1M MES, 15% PEG4000, 0.125M (NH4)2SO4, 2% Benzamidine, pH 6.25, VAPOR DIFFUSION, SITTING DROP, temperature 296K
分辨率 2.15 Å R-free 0.208
5CSF S100B-RSK1 crystal structure A 提交 2015-07-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 C 683–735(53 aa) 片段:UNP residues 683-735
未记录 CA CALCIUM ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;296 K;0.1 M Hepes 7, 150 mM NaCl, 20% PEG6000
分辨率 2.40 Å R-free 0.291
5CSI S100B-RSK1 crystal structure A' 提交 2015-07-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 C 689–735(47 aa) 片段:UNP residues 689-735
未记录 CA CALCIUM ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;296 K;0.1 M Hepes 7, 150 mM NaCl, 20% PEG6000
分辨率 2.13 Å R-free 0.250
5CSJ S100B-RSK1 crystal structure B 提交 2015-07-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 C 696–735(40 aa) 片段:UNP residues 696-735
未记录 CA CALCIUM ION × 4 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;296 K;0.1 M Hepes 7, 150 mM NaCl, 20% PEG6000
分辨率 2.70 Å R-free 0.276
5CSN S100B-RSK1 crystal structure C 提交 2015-07-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 C 683–720(38 aa) 片段:UNP residues 683-720
未记录 CA CALCIUM ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;296 K;0.1 M Hepes 7, 150 mM NaCl, 20% PEG6000
分辨率 2.95 Å R-free 0.279
5N7D MAGI-1 complexed with a RSK1 peptide 提交 2017-02-20 Assembly 1 信息不足 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 697–744(48 aa)
未记录 GOL GLYCEROL × 3 CA CALCIUM ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;296 K;8% PEG 400, 100 mM acetate buffer
分辨率 2.30 Å R-free 0.227
5N7F MAGI-1 complexed with a pRSK1 peptide 提交 2017-02-20 Assembly 1 信息不足 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 688–735(48 aa)
非标准单体:是(mmCIF未提供具体位点) GOL GLYCEROL × 3 CA CALCIUM ION × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;296 K;14% PEG 8000, 200 mM MgCl2, 100 mM TRIS
分辨率 2.30 Å R-free 0.240
5N7G MAGI-1 complexed with a synthetic pRSK1 peptide 提交 2017-02-20 Assembly 1 信息不足 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 729–735(7 aa) 片段:UNP residues 88-94
非标准单体:是(mmCIF未提供具体位点) GOL GLYCEROL × 3 CA CALCIUM ION × 6 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;296 K;14% PEG 8000, 200 mM MgCl2, 100 mM TRIS
分辨率 2.95 Å R-free 0.264
5V61 Phospho-ERK2 bound to bivalent inhibitor SBP2 提交 2017-03-15 Assembly 1 信息不足 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 I 713–729(17 aa) 片段:UNP Q15418 residues 713-729, UNP P04608 residues 730-738
未记录 GOL GLYCEROL × 3 FRZ 5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE × 1 90A 2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;0.1 M Bis-Tris pH 6.5, 45% v/v polypropylene glycol P400
分辨率 2.20 Å R-free 0.212
5V62 Phospho-ERK2 bound to bivalent inhibitor SBP3 提交 2017-03-15 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 I 713–729(17 aa) 片段:UNP residues 713-729
非标准单体:是(mmCIF未提供具体位点) GOL GLYCEROL × 5 FRZ 5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE × 1 AKS N-(hex-5-yn-1-yl)hexanamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;277 K;0.1 M Tris-Bicine pH 8.5, 0.02 M each of 1,6-Hexanediol, 1-Butanol, 1,2-Propanediol, 2-Propanol, 1,4-Butanediol, 1,3-Propanediol, 20% v/v PEG550MME, 10% w/v PEG20,000
分辨率 1.90 Å R-free 0.203
7P74 The PDZ domain of SYNJ2BP complexed with the phosphorylated PDZ-binding motif of RSK1 提交 2021-07-19 Assembly 1 信息不足 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 725–735(11 aa)
突变:N-terminal biotin-ttds label 非标准单体:是(mmCIF未提供具体位点) CA CALCIUM ION × 4 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;100mM ammonium sulfate, 100mM sodium formate, 25% PEG smear broad
分辨率 1.90 Å R-free 0.211
7PC8 The PDZ domain of SNTG1 complexed with the phosphomimetic mutant PDZ-binding motif of RSK1 提交 2021-08-03 Assembly 1 信息不足 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 726–735(10 aa)
未记录 CA CALCIUM ION × 5 GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.15 M Lithium sulfate, 0.05 M Magnesium chloride hexahydrate ,0.1 M HEPES 7.8, 20 % v/v PEG Smear High
分辨率 2.50 Å R-free 0.232
7PC8 The PDZ domain of SNTG1 complexed with the phosphomimetic mutant PDZ-binding motif of RSK1 提交 2021-08-03 Assembly 2 信息不足 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 D 726–735(10 aa)
未记录 CA CALCIUM ION × 4 GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.15 M Lithium sulfate, 0.05 M Magnesium chloride hexahydrate ,0.1 M HEPES 7.8, 20 % v/v PEG Smear High
分辨率 2.50 Å R-free 0.232
7QQL The PDZ domain of SNTG2 complexed with the phosphorylated PDZ-binding motif of RSK1 提交 2022-01-10 Assembly 1 信息不足 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 F 725–735(11 aa)
非标准单体:是(mmCIF未提供具体位点) CA CALCIUM ION × 5 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;298 K;0.1 M Succinic acid pH 7.0 15% w/v PEG 3350
分辨率 2.44 Å R-free 0.230
7QQL The PDZ domain of SNTG2 complexed with the phosphorylated PDZ-binding motif of RSK1 提交 2022-01-10 Assembly 2 信息不足 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 E 725–735(11 aa)
非标准单体:是(mmCIF未提供具体位点) CA CALCIUM ION × 4 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;298 K;0.1 M Succinic acid pH 7.0 15% w/v PEG 3350
分辨率 2.44 Å R-free 0.230
7QQL The PDZ domain of SNTG2 complexed with the phosphorylated PDZ-binding motif of RSK1 提交 2022-01-10 Assembly 3 信息不足 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 D 725–735(11 aa)
非标准单体:是(mmCIF未提供具体位点) CA CALCIUM ION × 5 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;298 K;0.1 M Succinic acid pH 7.0 15% w/v PEG 3350
分辨率 2.44 Å R-free 0.230
8WF4 The Crystal Structure of RSK1 from Biortus. 提交 2023-09-19 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 411–735(325 aa)
未记录 EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.1M Hepes pH7.0, 15% PEG 20000
分辨率 2.65 Å R-free 0.309
8WF4 The Crystal Structure of RSK1 from Biortus. 提交 2023-09-19 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 411–735(325 aa)
未记录 EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.1M Hepes pH7.0, 15% PEG 20000
分辨率 2.65 Å R-free 0.309
8XOV The Crystal Structure of N-terminal kinase domain of human RSK-1 from Biortus. 提交 2024-01-02 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 33–353(321 aa)
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1 EDO 1,2-ETHANEDIOL × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.1M MgAC2, 0.1M Nacacodylate pH6.5, 15% PEG 6000
分辨率 2.55 Å R-free 0.252